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Abstract 
Context: Persons with late-stage dementia have limited access to palliative care. 
Objective:  To test dementia-specific specialty palliative care triggered by hospitalization. 
Methods: This pilot randomized controlled trial enrolled 62 dyads of persons with late-stage dementia 
and family decision-makers on admission to hospital. Intervention dyads received dementia-specific 
specialty palliative care consultation plus post-acute transitional care.  Control dyads received usual 
care and educational information. The primary outcome was 60-day hospital or emergency department 
visits. Secondary patient and family-centered outcomes were patient comfort, family distress, palliative 
care domains addressed in the treatment plan, and access to hospice or community-based palliative 
care.  Secondary decision-making outcomes were discussion of prognosis, goals of care, completion of 
Medical Orders for Scope of Treatment (MOST), and treatment decisions.  
Results:  Of 137 eligible dyads, 62 (45%) enrolled. The intervention proved feasible, with protocol 
completion ranging from 77% (family 2-week call) to 93% (initial consultation).  Hospital and emergency 
department visits did not differ (intervention vs control, 0.68 vs 0.53 transfers per 60 days, p=0.415).  
Intervention patients had more palliative care domains addressed, and were more likely to receive 
hospice (25% vs 3%, p<0.019).  Intervention families were more likely to discuss prognosis (90% vs 
3%, p<0.001) and goals of care (90% vs 25%, p<0.001), and to have a MOST at 60-day follow-up (79% 
vs 30%, p<0.001).  More intervention families made decisions to avoid re-hospitalization (13% vs 0%, 
p=0.033). 
Conclusion: Specialty palliative care consultation for hospitalized patients with for late-stage dementia 
is feasible and promising to improve decision-making and some treatment outcomes.   
 
Clinicaltrials.gov:  NCT02719938 (3/21/16)  
 
Key words: dementia, randomized trial  
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Introduction 
Alzheimer’s disease and related dementias are leading causes of functional dependency and 
death.  Over 5 million Americans live with dementia; more than 1 million have late-stage dementia with 
profound cognitive deficits and dependence for activities of daily living.1,2 Family caregivers provide 
extraordinary practical and emotional support, and face average out-of-pocket expenses of $66,000 in 
the last year of life.3,4  Societal costs for dementia care exceeded $250 billion in 2018, and the affected 
population is projected to double by 2030.5,6   
Dementia is the only leading cause of death in the United States without meaningful treatment 
to prevent, cure or slow disease progression.  Palliation should be an important focus of dementia care, 
yet the evidence shows unmet need.  Among nursing home residents with dementia, half experience 
frequent and unrelieved pain.7,8,9  Distressing symptoms -- shortness of breath, neuropsychiatric 
symptoms, feeding problems, and problems with personal cleanliness -- are common.10,11,12,13,14 
Decisions about life-sustaining treatment are delayed, and access to hospice limited by lack of a 
discrete terminal phase of illness.15,16,17,18 
Hospitalization is common in late-stage dementia, creating an opportunity to improve access to 
palliative care.19  While only 27% of US nursing homes report any type of specialized palliative or end-
of-life care, 85% of large hospitals have specialty palliative care.20,21 Infections, hip fracture and 
nutritional decline are common reasons for hospital transfer, and signal worsened prognosis with six-
month mortality risk of 20-50%. 15,22,23,24,25  
Specialty palliative care improves treatment decision-making and other patient-centered 
outcomes for persons with cancer and other serious illnesses, but has rarely been studied for persons 
with dementia.26,27,28,29,30 Palliative care clinicians rarely have training for dementia-specific symptom 
management, decision-making and caregiver support, yet their fundamental skills and interdisciplinary 
team approach is well matched to needs in late-stage dementia.  We therefore developed a model of 
specialty palliative care consultation specific to the needs of persons with late-stage dementia and their 
families.   Specific aims were 1) to develop a best-practice model of specialty palliative care for late-
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stage dementia, and 2) to conduct a pilot randomized trial of specialty palliative care for late-stage 
dementia triggered by hospitalization for acute illness.  We hypothesized this model would be feasible, 
and show potential to improve outcomes of subsequent hospital or emergency department visits, 
hospice and community-based palliative care use, enhanced palliative care content of care plans, 
increased completion of MOST (Medical Orders for Scope of Treatment) forms, and decisions to avoid 
future hospitalization and potentially burdensome treatments. 
Methods 
Trial design:  Investigators reviewed evidence on palliative care needs and interventions in late-
stage dementia.  They held 3 meetings with key stakeholders – 3 family caregivers for persons with 
late-stage dementia and 4 clinicians with extensive experience in dementia care.  Using these sources, 
investigators designed a dementia-specific protocol for specialty palliative care consultation with post-
acute telephone support.  
Research staff enrolled dyads of hospitalized persons with late-stage dementia with their 
primary family decision-makers, and randomized them to receive specialty palliative care consultation 
during hospitalization with post-discharge telephone support by a palliative care nurse practitioner 
(intervention) vs usual hospital care with educational material on dementia caregiving (control).  The 
University of North Carolina institutional review board approved the protocol, and a Data Safety Monitor 
reviewed study procedures and preliminary data every six months; the study is a registered clinical trial 
(NCT 02719938).   
Participant enrollment and randomization:  From March 31, 2016 to August 31, 2017 research 
staff enrolled dyads of hospitalized patients with late-stage dementia and family decision-makers. 
Investigators developed and refined a dementia phenotype within the hospital electronic health record 
(EHR) based on patient age, hospital admission date and ever use of ICD-9 or ICD-10 codes for 
dementia diagnoses.31  Potentially eligible patients were thus identified within 24 hours of admission, 
reviewed by research staff for eligibility.  A palliative care physician then confirmed dementia diagnosis 
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and stage with the patient’s attending physician, and sought permission to approach the family 
decision-maker about participation.  
Patients were eligible if they were aged 65 or older, hospitalized with an acute illness, had a 
diagnosis of dementia stage 5-7 on the Global Deterioration Scale (GDS) verified by their attending 
physician, and had an eligible family decision-maker.32  Persons with GDS 5 dementia and later cannot 
live independently and are frequently disoriented, while those who progress to GDS 7 have sparse 
speech, dependency for all activities, and cannot recognize family. Family decision-makers were 
eligible if they were legally authorized representatives for healthcare decisions and could complete 
interviews in English.  They provided written consent for themselves and the person with late-stage 
dementia.  After informed consent, the study biostatistician randomized each dyad in a 1:1 ratio to 
intervention vs. control arms prior to the baseline interview.  Allocation was revealed to the baseline 
interviewer, family decision-maker and to the attending physician, but concealed from the investigators 
and research staff collecting interview outcome data. Family decision-makers were compensated for 
time to complete interviews.  
Intervention and control conditions: Patient-family dyads randomized to the intervention 
received protocolized specialty palliative care consultation while hospitalized, plus 2-week post-
discharge transitional telephone support by a palliative care nurse practitioner. Clinicians delivering the 
intervention were board-certified physicians and nurse practitioners in palliative care.  The consult 
protocol addressed a) stage, prognosis and trajectory of dementia, b) assessment and treatment of 
pain and other physical symptoms, c) assessment and management of neuropsychiatric symptoms, d) 
social support for caregiver stress, e) spiritual needs assessment, f) cultural concerns framing care, g) 
goals of care decision-making, and h) key clinical decisions such as feeding options, antibiotic use, and 
re-hospitalization.  Consultants provided families with a copy of the informational booklet “Advanced 
Dementia: A Guide for Families.”33 Based on their assessments, consultants provided individualized 
recommendations for palliative care domains, offered to assist with completion of a Medical Orders for 
Scope of Treatment (MOST) order set, the North Carolina version of POLST (Physician Orders for Life 
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Sustaining Treatment), and recommended referrals to post-discharge services. 34,35 Transitional care 
included a) provision of consult recommendations and MOST form to the post-acute primary provider, 
and b) follow-up supportive calls by a Palliative Care nurse practitioner to the family decision-maker at 
72 hours and 2 weeks post-discharge.  Investigators provided a 1-hour training session to Palliative 
Care physicians and nurse practitioners to teach them the dementia protocol, and to provide access to 
an EHR-templated consult note.   
Family decision-makers randomized to control received information on caregiving for late-stage 
dementia from the Alzheimer’s Association, and patients received usual hospital care.36  Specialty 
palliative care consultation was allowed, if requested by attending physicians.  All other procedures 
were identical for intervention and control participants. 
Data Collection:  Research staff masked to study arm collected data using 30- and 60-day post-
discharge telephone interviews with family decision-makers. When an enrolled patient died, staff 
conducted family interviews with modifications for care during dying. A separate research staff member  
conducted chart reviews at 60 days post-discharge, but could not be masked due to the differential 
documentation between study arms.   
Feasibility: Investigators evaluated feasibility based on dyad enrollment and follow-up, and on 
fidelity to components of the intervention. Research staff monitored six components (initial consult, call 
to post-acute provider, palliative care consult records to post-acute provider, MOST discussion, 72-hour 
call to family and 2-week call to family), with a goal of 80% completion.   
Outcomes:  The pre-specified primary outcome was hospital or emergency department visits in 
the 60 days post-discharge, defined as hospital re-admissions or emergency room visits reported in 
family interviews. Secondary patient and family-centered outcomes were patient comfort, family 
distress, palliative care domains addressed in the treatment plan, and access to hospice or community-
based palliative care services.  Secondary decision-making outcomes were discussion of prognosis, 
discussion of goals of care, completion of MOST (Medical Orders for Scope of Treatment) order set, 
and documented decisions against re-hospitalization or other potentially burdensome treatments.  
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Patient comfort was measured in follow-up interviews using the reliable and valid Comfort at the 
End of Life in Dementia (CAD-EOLD).  Fourteen items are rated 1-3 and summed, for a range of 14-42 
with higher scores indicating better symptom control over the past week.  It has good internal 
consistency (Cronbach’s alpha 0.83-0.90) and convergent validity (r=0.81 with the Decision Satisfaction 
Inventory).37,38  Family distress was measured using the Family Distress in Advanced Dementia (FDAD) 
scale, with 21 items rated and averaged on a 1-5 scale to create a potential range of 1-5, with higher 
scores indicating greater distress. The FDAD has good internal consistency in 3 domain scores for 
emotional distress (alpha=0.82), dementia preparedness (0.75) and clinician relations (0.83).39 
Palliative care domains (range 0-10) were measured in chart review as count of the presence or 
absence of 10 domains of palliative care addressed in the medical treatment plan -- prognosis, overall 
goals of care, physical symptoms, psychiatric symptoms, spiritual needs, and 5 treatment preferences:  
resuscitation, artificial feeding, intravenous fluids, antibiotics, and hospitalization. This measure has 
been used in a large clinical trial, and has good inter-rater reliability (kappa =0.90)40 Access to hospice 
or community-based palliative care, MOST completion and decision-making about specific treatments 
was measured using family report at 60 days, with verification in medical record review.  Finally, 
research assistants reviewed charts for evidence of adherence to process measures for dementia 
quality of care using the Physician Quality Reporting System (PQRS) 2015 measures for dementia 
staging (#280), cognitive assessment (#281), functional assessment (#282), neuropsychiatric symptom 
assessment (#283), safety counseling (#286), and caregiver education and support (#288).41 
Additional Variables:  Research staff recorded data on patient and family decision-maker 
demographics, prior hospital transfers, and advance directives from baseline family interviews.  Patient 
functional status was measured in baseline family interviews using the valid and reliable Bedford 
Alzheimer Nursing Severity scale (BANS-S), framed to represent function in the weeks just prior to 
acute illness.42  The BAN-S ranges 7-28, with higher scores indicating greater functional impairment.  
During baseline and follow-up interviews, research staff asked family respondents about their 
perception of prognosis for the person with dementia, and perception of their involvement in decision-
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making.  During chart review, staff recorded data on major co-morbid diagnoses and the acute illness 
causing hospital admission, post-acute site of care and patient’s vital status at 60 days follow-up.   
Analysis:  Patient-family dyads were the primary unit of analysis. Baseline characteristics of the 
dyads were reported in either means and standard deviations or medians and ranges if the variables 
are continuous, and in percentages if the variables are categorical.  Intervention and control dyads 
were then compared on the baseline characteristics to explore possible differences between arms after 
randomization. All of the comparisons were tested using either chi-square tests or two-sample t-tests 
except hospital length of stay, which was compared using Mann-Whitney test because of non-
normality. The primary outcome of hospital and emergency department visits was reported as the 
number of events per 60 days of follow-up, with censoring of eligible follow-up days if the patient died or 
the dyad withdrew from the study. In a priori power calculation, the sample size of 60 patients with 30 
patients per group was estimated to give 81% power to detect a relative risk of 2.7. Poisson regression, 
which accounts for the length of follow-up, was used to compare the rate of hospital and emergency 
department visits between the two arms. Comparisons of the secondary outcomes were implemented 
using either chi-square tests or two-sample t-tests, when appropriate. Comparisons were not further 
adjusted since there was no apparent imbalance between arms. All analyses used intention-to-treat 
assignment, with a p value <0.05 threshold for statistical significance. Software SAS 9.4 (Cary, NC) 
was used to implement statistical tests. 
 
Results 
Study Enrollment and Feasibility:  Automated screening generated 3296 admissions with a 
dementia diagnosis code during the 18-month enrollment period, of whom 426 had late-stage 
dementia. (Figure 1) One-third of patients were discharged prior to contact due to very short lengths of 
stay (n=161), and others were admitted during periods when study personnel were not available 
(n=50).  Some were not eligible due to active dying or current hospice enrollment (n=32), attending 
physician refusal (n=29), or lack of eligible decision-maker (n=17).  Of 137 eligible dyads contacted, 62 
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(45%) enrolled and randomized (32 control, 30 intervention). One-third of family caregivers who refused 
participation stated this was due to feeling overwhelmed by caregiving and other roles. After enrollment, 
one family decision-maker withdrew and 4 were lost to follow-up.   Fidelity to the intervention was high, 
with completion of each of six intervention protocol components ranging from 77% (family 2-week call) 
to 93% (palliative care consultation).   
Characteristics of enrolled patients and families:  Hospitalized patients with late-stage dementia 
had an average age of 83.9 years, 56% were female, 71% white and 24% African American. (Table 1)  
Thirty-seven percent had GDS Stage 5, 42% Stage 6 and 21% Stage 7 dementia.  The most common 
admitting diagnoses were infections and neuropsychiatric symptoms. Two-thirds of patients had 
advance directives.  Baseline characteristics did not differ significantly between study arms.   
Family decision-makers had an average age of 59.7 years, 79% were female, and more than 
half were daughters. At enrollment, 92% of caregivers felt they were very involved in treatment 
decisions for the person with dementia, and 60% expected that person to get worse or possibly die in 
the next 6 months.  
Patient and family-centered outcomes:  One of three enrolled patients with late-stage dementia 
visited an emergency department or was hospitalized in the 60 days after discharge.  The primary 
outcome of 60-day hospital or emergency department visits did not differ significantly between 
intervention and control arms (0.68 vs 0.53 visits, p=0.415).  (Table 2)  Family caregivers’ ratings of 
comfort for the person with dementia and of distress for themselves did not differ between arms at 60 
days.  However, dementia patients in the intervention arm had more elements of clinical palliative care 
addressed in their hospital treatment plan, as measured on the 10-point Palliative Care Domain score 
(7.6 vs 2.7, p<0.001).  Patients with the intervention were more likely to have assessment and 
treatment for physical symptoms of dyspnea, constipation and nausea, and for neuropsychiatric 
symptoms.  Spiritual needs were addressed for 47% of patient-family dyads in the intervention arm, and 
for 0% of those in the control arm.  In the 60 days after discharge, family reported that patients in the 
intervention arm were more likely to receive hospice (25% vs 3%, p<0.019), with a trend toward greater 
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access to community-based palliative care.  In the intervention arm, more patients with dementia 
discharged to home or assisted living settings, while patients in the control arm were more likely to 
enter nursing homes (p=0.046).  As anticipated, few patients died during follow-up and mortality did not 
differ between arms. 
Decision-making outcomes:  Specialty palliative care during hospitalization also resulted in 
increased communication and decision-making about treatments relevant to late-stage dementia.  
Family decision-makers in the intervention arm were more likely to participate in discussions of 
prognosis (90% vs 3%, p<0.001) and goals of care (90% vs 25%, p<0.001).  These families were more 
likely to complete a MOST in hospital (70% vs 13%, p<0.001) and have an active MOST in use at 60 
day follow-up (79% vs 30%, p<0.001).  While Do-Not-Resuscitate orders were common for persons 
with dementia in both arms, more intervention families made decisions to avoid future burdensome 
treatments such as tube feeding, antibiotics and IV fluids.  Decisions to avoid re-hospitalization were 
also increased (13% vs 0%, p=0.033). 
Dementia quality of care:  Compared to controls, persons with dementia in the intervention arm 
were more likely to receive formal dementia staging (93% vs 9%, p<0.001) and structured assessment 
of cognition (73% vs 9%, p<0.001) and function (97% vs 25%, p<0.001).  Neuropsychiatric symptoms 
were more commonly addressed, as were caregivers’ safety concerns.  Finally, this intervention 
resulted in more education of family caregivers about late-stage dementia (80% vs 25%, p<0.001). 
 
Discussion 
Specialty palliative care consultation specific to late-stage dementia, initiated during 
hospitalization for acute illness, is feasible and promising to improve decision-making and clinical 
outcomes for persons with dementia and their families.  In this pilot randomized trial, investigators used 
an innovative, efficient method to identify hospitalized patients with late-stage dementia.  Compared to 
usual hospital care, triggered palliative care consultation was effective to improve decision-making, 
dementia neuropsychiatric symptom management, and use of hospice. While the intervention did not 
change the primary outcome of 60-day hospital or emergency department visits, it did increase 
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decisions to forego further hospitalization and thus may affect this outcome over longer follow-up.  
Family decision-makers were more likely to discuss prognosis and goals of care, and make decisions to 
avoid burdensome treatments for the person with dementia.  Furthermore, they were much more likely 
to record these decisions in a MOST order set, and these orders remained in use 60 days after hospital 
discharge.   
Persons with dementia and their families need intervention research to reduce or 
moderate the effects of frequent healthcare transitions – including hospitalizations and 
admissions to nursing facilities.  We found that one in three persons with dementia returned to a 
hospital or emergency room in the 60 days after discharge. Stakeholders interviewed in 
preparation for this trial likened the experience of late-stage dementia healthcare to “being 
nomads” and “becoming homeless.”  They referenced frequent hospitalizations and transitions to 
nursing facility care, resulting in the loss of a trustworthy primary clinician to guide treatment.  
While facility placement was not a pre-specified outcome, an unexpected finding in this study was 
that fewer persons with dementia in the intervention arm entered nursing home care.  It is 
possible that skilled discussions of prognosis and goals of care supported families to opt for home 
or home-like assisted living facilities with dementia care units. 
This pilot trial is an important addition to very limited research on specialty palliative care 
for dementia, and its promising intermediate outcomes warrant testing in a larger trial.  A small 
randomized trial of specialty palliative care consultations for hospitalized patients with dementia 
found increased use of palliative care plans (23% vs 4%, p=0.008) and reduction in intravenous 
therapies (66% vs 81%, p=0.025), but no effect on life-sustaining treatment decisions.43  In a 
small pre-post study (n=52), proactive case-finding of intensive care unit patients with advanced 
dementia for palliative care was associated with fewer hospital days (7.4 vs 12.1, p<0.007) and 
ICU days (3.5 vs 6.8, p<0.004), with no difference in overall treatment intensity.44  Mitchell 
conducted a single site pre-post pilot study of an Advanced Dementia Consult Service, which 
provided post-acute recommendations to the primary physician, and a follow-up call to the family 
caregiver.  Investigators enrolled 24 controls followed by 5 intervention participants, and found 
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promising trends in increased hospice use (40% vs 25%), reduced 30-day re-admissions (0% vs 
29%), and improved family understanding of advanced dementia (50% vs 0%).45   
Investigators have also tested interventions in which non-specialty clinicians deliver 
elements of palliative care, termed “primary palliative care.”  Our research team has extensive 
experience in primary palliative care interventions for dementia, delivered by interdisciplinary 
nursing home staff and geriatric care teams in nursing homes, assisted living, and in the 
community.  In the nursing home setting, we have shown that dementia-specific decision aids can 
improve communication and decision-making for family caregivers, enhance palliative care 
treatment plans, improve goal-concordant care, and reduce hospitalizations.46,47,48,49,50  Ongoing 
clinical trials include primary palliative care interventions to improve decision-making about 
treatment for infection in advanced dementia (TRAIN-AD AG032982) in nursing homes and 
dementia palliative care delivered community-dwelling patients and their families (IN PEACE 
AG057733). Given the large population of persons with Alzheimer’s and related dementias, and 
the prolonged suffering associated with this condition, improvements in both specialty and primary 
palliative care are necessary to improve outcomes. 
Meaningful interpretation of our results requires consideration of limitations.  This pilot 
clinical trial provides promising evidence for feasibility and efficacy, yet a statistically powered 
efficacy trial is necessary to prove this intervention can reduce hospital transfers and improve 
other outcomes important to persons with dementia and caregivers such as comfort and caregiver 
distress.  As expected in a pilot trial this study had limited statistical power. In addition, the 
duration of specialty palliative care may need to be extended beyond discharge to affect these 
important outcomes. The study site has robust clinical resources in palliative care and geriatric 
care, and multi-site testing is needed to ensure this model can be exported and replicated.  Study 
participation was good, but many persons with dementia could not be enrolled due to short 
hospital stays and caregiver stresses.  Enrollment and outcomes may be improved if the 
intervention includes extended post-discharge specialty palliative care services, or access to 
services by telemedicine. As persons with dementia experience transitions between hospital, 
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emergency room, nursing home, home or assisted living settings it may be important to offer 
enhanced elements of transitional care.51,52 
Specialty palliative care tailored to late-stage dementia, triggered by hospitalization for acute 
illness, is feasible and demonstrates potential to improve decision-making and clinical outcomes for 
persons with dementia and their families.  This promising new model for dementia palliative care was 
designed using stakeholder input and evidence-based standards for dementia care.  Results from this 
research will be used to develop a multi-site randomized controlled trial of specialty palliative care for 
hospitalized patients with late-stage dementia. 
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Figure 1: Enrollment and Participant Flow 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
3296 hospitalized patients 
screened with dementia 
 
766 possible late-stage 
dementia 
426 physician confirmed 
late-stage dementia 
2530 not late-stage dementia  
 
340 not late-stage dementia 
 
137 eligible dyads 
62 dyads enrolled and 
randomized 
289 ineligible: 
- 161 discharge before contact 
- 32 actively dying / hospice 
- 29 attending refused 
- 17 no decision-maker eligible 
- 50 study personnel unavailable 
 
75 Refused 
- 25 overwhelmed 
- 14 unable to visit hospital 
- 36 other 
30 intervention dyads  
 
32 control dyads  
26 complete follow-up data 
(60 days) 
1 withdrew 
3 lost to follow-up 
 
31 complete follow-up data 
(60 days) 
0 withdrew 
1 lost to follow-up 
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Table 1. Characteristics of Patients with Late-stage Dementia & Family Decision-makers. 
Patient Characteristics 
TOTAL 
N=62 
Intervention 
N=30 
Control 
N=32 P value 
Patient age, mean (SD) 83.9 (8.7) 83.0 (8.8) 84.7 (8.7) 0.434 
Patient female, % 56% 67% 47% 0.116 
Patient race, %  
     White 
     African American 
     Other 
 
71% 
24% 
5% 
 
70% 
27% 
3% 
 
72% 
22% 
6% 
0.808 
Patient Hispanic or Latino, %  5% 3% 6% 0.593 
GDS * Stage, % 
     5 
     6 
     7 
 
37% 
42% 
21% 
 
43% 
40% 
17% 
 
31% 
44% 
25% 
 
0.556 
BANS-S ** , mean (s.d.) 15.9 (3.6) 15.4 (3.5) 16.3 (3.6) 0.271 
Admitting diagnosis in chart review 
     Urinary tract infection 
     Sepsis 
     Neurospychiatric symptoms 
     Hip fracture 
     Pneumonia  
     Dehydration/malnutrition  
     Delirium 
     Other 
 
28% 
16% 
15% 
11% 
8% 
8% 
6% 
8% 
 
37% 
13% 
17% 
3% 
3% 
7% 
7% 
13% 
 
19% 
19% 
13% 
19% 
13% 
          9% 
6% 
2% 
 
0.114 
0.562 
0.642 
0.055 
0.185 
0.700 
0.947 
0.298 
Hospitalized in past 30 d. 
ER in past 30 d. 
10% 
35% 
10% 
40% 
9% 
31% 
0.934 
0.472 
Prior advance directive 63% 63% 63% 1.000 
Pre-admission residence 
     Home 
     Assisted living 
     Nursing home  
     other 
 
51% 
18% 
26% 
5% 
 
43% 
30% 
23% 
4% 
 
60% 
6% 
28% 
6% 
 
0.107 
Hospital length of stay, median (range) 6 (2-36) 6 (2-36) 6 (2-32) 0.437 
Family Decision-maker Characteristics    
 
Family decision-maker age, mean (SD) 59.7 (10.5) 60.0 (9.9) 59.5 (11.1) 0.844 
Family decision-maker female, %  79% 73% 84% 0.286 
Family decision-maker race, %  
     White 
     African American 
     Other 
 
71% 
24% 
5% 
 
70% 
27% 
3% 
 
72% 
22% 
6% 
 
0.808 
Hispanic or Latino, % 2% 0% 3% 0.329 
Relationship to person with dementia, % 
     Daughter  
     Son 
     Spouse 
     Other 
 
52% 
18% 
19% 
11% 
 
47% 
27% 
20% 
6% 
 
56% 
9% 
19% 
16% 
 
0.262 
Family decision involvement, % 
     Not at all involved 
     Somewhat involved 
     Very involved 
 
0% 
10% 
90% 
 
0% 
14% 
86% 
 
0% 
6% 
97% 
 
0.323 
Family perceived 6-month prognosis, % 
     Get better 
     Stay same 
     Get worse 
     Likely to die 
 
 
17% 
23% 
37% 
23% 
 
 
17% 
23% 
40% 
20% 
 
 
17% 
23% 
33% 
27% 
 
 
0.926 
*GDS=Global Deterioration Scale, range 1-7, higher stage indicates more advanced dementia 
**BANS-S=Bedford Alzheimer’s Nursing Severity-Subscale, range 7-28, higher scores indicate more functional disability 
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       Table 2. Outcomes of Triggered Palliative Care for Persons with Late-stage Dementia. 
 
Outcomes 
Intervention 
N=30 
Control 
N=32 P value 
Primary Outcome 60 d 60 d  
Hospital / emergency visits per 60 days (no. of events/follow-up 
days)  
0.68 (21/1843)  0.53  (20/2264) 0.415 
Patient and Family Centered Secondary Outcomes  
   
Patient comfort (CAD-EOLD*), mean (SD) (range 14-42)  34.8 (4.2) 34.0 (4.1) 0.521 
Family caregiver distress (FDAD**), mean (SD) (range 1-5) 2.3 (0.5) 2.4 (0.5) 0.409 
Palliative Care Domain Index (0-10)  in hospital care plan 7.6 (2.5) 2.7 (1.7) <0.001 
Physical symptom addressed  
          Pain 
          Dyspnea 
          Constipation 
          Poor appetite 
          Nausea 
          Falls 
 
87% 
77% 
93% 
37% 
90% 
33% 
 
72% 
34% 
25% 
38% 
25% 
16% 
 
0.153 
<0.001 
<0.001 
0.946 
<0.001 
0.104 
Neuropsychiatric symptom addressed  
          Depression 
          Anxiety 
          Decreased level of consciousness 
          Hyperactive delirium 
 
83% 
83% 
67% 
80% 
 
25% 
16% 
22% 
19% 
 
<0.001 
<0.001 
<0.001 
<0.001 
Spiritual needs addressed  47% 0%    <0.001 
Hospice at 60 days 25% 3% 0.019 
Community Palliative Care at 60 days 21% 7% 0.124 
Hospital discharge location  
    Home 
    Assisted living 
    Nursing home  
    Death 
    Other 
 
33% 
24% 
33% 
0% 
10% 
 
25% 
3% 
63% 
0% 
9% 
 
0.046 
Patient vital status alive at 60 days, %  87% 94% 0.346 
Decision-making Secondary Outcomes 
   
 Documented discussion of prognosis, % YES  90% 3% <0.001 
 Documented discussion of goals of care, % YES 90% 25% <0.001 
 MOST+  completion at 60 days 79% 30% <0.001 
 Code status in hospital 
      Full code  
      DNR, present at admission 
      DNR, new  
 
27% 
53% 
20% 
 
22% 
66% 
12% 
 
0.583 
Decision not to re-hospitalize  13% 0% 0.033 
Decision made NOT to tube feed 53% 6% <0.001 
Decision made NOT to use antibiotics 
Decision made to LIMIT use of antibiotics 
7% 
43% 
3% 
0% 
<0.001 
Decision made NOT to use IV fluids 
Decision made to LIMIT use of IV fluids 
13% 
43% 
6% 
3% 
<0.001 
Dementia Care Quality Metrics (chart review) 
   
 Dementia staged 
 Cognitive assessment 
 Functional assessment 
 Neuropsychiatric symptoms addressed 
 Safety concerns addressed 
 Caregiver education 
93% 
73% 
97% 
83% 
83% 
80% 
9% 
9% 
25% 
25% 
44% 
25% 
  <0.001 
  <0.001 
<0.001 
<0.001 
0.001 
<0.001 
 
     *CAD-EOLD=Comfort Assessment in Dying, End of Life in Dementia, range overall 14-42, higher scores indicate more 
comfort 
     **FDAD=Family Distress in Advanced Dementia, range overall and subscales 1-5, higher scores indicate more distress  
     
+MOST=Medical Orders for Scope of Treatment, the North Carolina version of POLST (Physician Orders for Life Sustaining  
                   Treatment) order set 
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